A global market access journey in cannabinoid pharmaceuticals

Pharma Market Access Insights - from Mtech Access

What does it take to bring a cannabinoid pharmaceutical to market?
We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the Pharma industry can learn from their journey.
In the webinar, Clare asked Michael about:
- Drug development and clinical trial processes for medical cannabis products
- Differences between the herbal medicines market and the Pharmaceutical market
- Overcoming regulatory and reimbursement challenges
- Finding the right place for cannabinoid medicines within existing pathways of care
- Perceptions, pathways and routes to access in different markets
- Lessons for the wider Pharma and Biotech industries
Learn more about this webinar and our guest speaker Michael Sassano at: https://mtechaccess.co.uk/global-market-access-journey-cannabinoid-pharmaceuticals/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Kapitler

1. Your vision for the future of SOMAÍ Pharmaceuticals (00:02:10)

2. Michael's career to date (00:04:36)

3. The journey from discovery to getting cannabis licensed as a medical product (00:07:28)

4. Challenges from regulators (00:13:18)

5. The reimbursement picture (00:24:21)

6. Benefit to patients and where these products offer potential (00:30:17)

7. Patient perception of cannabinoid medicines (00:37:11)

8. Lessons for the wider pharmaceutical industry (00:46:43)